Christa Dreezen

1.5k total citations
31 papers, 1.0k citations indexed

About

Christa Dreezen is a scholar working on Cancer Research, Infectious Diseases and Virology. According to data from OpenAlex, Christa Dreezen has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 12 papers in Infectious Diseases and 7 papers in Virology. Recurrent topics in Christa Dreezen's work include HIV/AIDS Research and Interventions (12 papers), Breast Cancer Treatment Studies (12 papers) and HIV Research and Treatment (7 papers). Christa Dreezen is often cited by papers focused on HIV/AIDS Research and Interventions (12 papers), Breast Cancer Treatment Studies (12 papers) and HIV Research and Treatment (7 papers). Christa Dreezen collaborates with scholars based in Belgium, United States and Netherlands. Christa Dreezen's co-authors include Éric Florence, Robert Colebunders, Annuska M. Glas, Ward Schrooten, Laura J. van’t Veer, Sjoerd C. Bruin, Corrie A.M. Marijnen, Ramón Salazar, Hans Morreau and Peter J.K. Kuppen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Christa Dreezen

30 papers receiving 984 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christa Dreezen Belgium 12 354 351 243 234 191 31 1.0k
Kelong Han United States 18 250 0.7× 220 0.6× 44 0.2× 128 0.5× 70 0.4× 41 928
Brian P. Mulhall Australia 18 254 0.7× 262 0.7× 122 0.5× 19 0.1× 171 0.9× 40 1.2k
Qiwen Fang China 11 187 0.5× 385 1.1× 93 0.4× 68 0.3× 42 0.2× 34 1.2k
Soo Aleman Sweden 21 357 1.0× 137 0.4× 53 0.2× 132 0.6× 177 0.9× 121 1.9k
Laura Farrelly United Kingdom 13 304 0.9× 192 0.5× 72 0.3× 38 0.2× 96 0.5× 49 874
James Kitinya Tanzania 18 150 0.4× 233 0.7× 95 0.4× 84 0.4× 20 0.1× 47 765
Jane Kelly United Kingdom 16 215 0.6× 133 0.4× 131 0.5× 115 0.5× 33 0.2× 33 1.1k
Alicia Young United States 14 207 0.6× 97 0.3× 100 0.4× 38 0.2× 168 0.9× 23 715
Sophie Limou France 20 213 0.6× 45 0.1× 68 0.3× 30 0.1× 162 0.8× 54 1.5k

Countries citing papers authored by Christa Dreezen

Since Specialization
Citations

This map shows the geographic impact of Christa Dreezen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christa Dreezen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christa Dreezen more than expected).

Fields of papers citing papers by Christa Dreezen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christa Dreezen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christa Dreezen. The network helps show where Christa Dreezen may publish in the future.

Co-authorship network of co-authors of Christa Dreezen

This figure shows the co-authorship network connecting the top 25 collaborators of Christa Dreezen. A scholar is included among the top collaborators of Christa Dreezen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christa Dreezen. Christa Dreezen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Veer, Laura van ‘t, Elma Meershoek‐Klein Kranenbarg, Marjolijn Duijm‐de Carpentier, et al.. (2024). Selection of Patients With Early-Stage Breast Cancer for Extended Endocrine Therapy. JAMA Network Open. 7(11). e2447530–e2447530. 1 indexed citations
3.
Krop, Ian E., Lorenza Mittempergher, Joseph N. Paulson, et al.. (2024). Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) Trial. JCO Precision Oncology. 8(8). e2200667–e2200667. 1 indexed citations
4.
Liefers, Gerrit‐Jan, Elma Meershoek‐Klein Kranenbarg, Marjolijn Duijm‐de Carpentier, et al.. (2023). Abstract GS5-10: Utility of the 70-gene MammaPrint test for prediction of extended endocrine therapy benefit in patients with early-stage breast cancer in the IDEAL Trial. Cancer Research. 83(5_Supplement). GS5–10. 6 indexed citations
5.
Dubsky, Peter, LJ van't Veer, Michael Gnant, et al.. (2021). A clinical validation study of MammaPrint in hormone receptor-positive breast cancer from the Austrian Breast and Colorectal Cancer Study Group 8 (ABCSG-8) biomarker cohort. ESMO Open. 6(1). 100006–100006. 10 indexed citations
6.
Mittempergher, Lorenza, Leonie Delahaye, Anke Witteveen, et al.. (2020). Performance Characteristics of the BluePrint® Breast Cancer Diagnostic Test. Translational Oncology. 13(4). 100756–100756. 22 indexed citations
7.
Delahaye, Leonie, Caroline A. Drukker, Christa Dreezen, et al.. (2017). A breast cancer gene signature for indolent disease. Breast Cancer Research and Treatment. 164(2). 461–466. 21 indexed citations
8.
Witteveen, Anke, Leonie Delahaye, Diederik Wehkamp, et al.. (2016). Equivalence of MammaPrint array types in clinical trials and diagnostics. Breast Cancer Research and Treatment. 156(2). 279–287. 36 indexed citations
9.
Witteveen, Anke, Christa Dreezen, Suet‐Feung Chin, et al.. (2016). Prognostic Value of MammaPrint® in Invasive Lobular Breast Cancer.. SHILAP Revista de lepidopterología. 2 indexed citations
10.
Witteveen, Anke, Christa Dreezen, Suet‐Feung Chin, et al.. (2016). Prognostic Value of MammaPrint® in Invasive Lobular Breast Cancer. Biomarker Insights. 11. BMI.S38435–BMI.S38435. 28 indexed citations
11.
Monsieurs, Koenraad G., et al.. (2014). Schoolchildren as BLS instructors for relatives and friends: Impact on attitude towards bystander CPR. Resuscitation. 85(12). 1769–1774. 35 indexed citations
12.
Salazar, Ramón, Paul Roepman, Gabriel Capellá, et al.. (2010). Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal Cancer. Journal of Clinical Oncology. 29(1). 17–24. 392 indexed citations
13.
Florence, Éric, Ward Schrooten, Christa Dreezen, et al.. (2004). Prevalence and factors associated with sexual dysfunction among HIV-positive women in Europe. AIDS Care. 16(5). 550–557. 54 indexed citations
14.
Florence, Éric, Christa Dreezen, Ward Schrooten, et al.. (2004). The role of non-viral load surrogate markers in HIV-positive patient monitoring during antiviral treatment. International Journal of STD & AIDS. 15(8). 538–542. 15 indexed citations
15.
Florence, Éric, Jens Lundgren, Christa Dreezen, et al.. (2003). Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV Medicine. 4(3). 255–262. 149 indexed citations
16.
Schrooten, Ward, Christa Dreezen, M.G.W. Dijkgraaf, et al.. (2002). Financial situation of people living with HIV in Europe. International Journal of STD & AIDS. 13(10). 698–701. 2 indexed citations
17.
Schrooten, Ward, Robert Colebunders, Mike Youle, et al.. (2001). Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment. AIDS. 15(8). 1019–1023. 90 indexed citations
18.
Schrooten, Ward, Christa Dreezen, Y. Fleerackers, et al.. (2001). Receiving a positive HIV test result: the experience of patients in Europe. HIV Medicine. 2(4). 250–254. 10 indexed citations
19.
Gisolf, Elizabeth H., et al.. (2000). Risk Factors for Hepatotoxicity in HIV-1--Infected Patients Receiving Ritonavir and Saquinavir with or without Stavudine. Clinical Infectious Diseases. 31(5). 1234–1239. 75 indexed citations
20.
Schrooten, Ward, et al.. (2000). Utilization of healthcare services by people living with HIV/AIDS in Europe. International Journal of STD & AIDS. 11(12). 784–789. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026